Helicos Amends Lease to Expire in March '10; Shrinks Facility by 10K Square Feet | GenomeWeb

By Julia Karow

This article was originally published Oct. 13.

Helicos BioSciences has given up part of its facility in Cambridge, Mass., and has extended its lease for the remainder until March 2010 or earlier.

In a filing with the Securities and Exchange Commission last week, the company said that it recently amended the lease for its 56,500-square-foot facility, consisting of its headquarters, research and development facility, and manufacturing plant.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.